STOCKHOLM, SE / ACCESSWIRE / April 26, 2022 / Promore Pharma (STO:PROMO) (FRA:8T0)
The 2021 Annual report of Promore Pharma AB (publ) and all AGM related documents are now available on the Company’s website.
The annual report is available in PDF format on the Company’s website at:
https://www.promorepharma.com/en/section/investors/financial-reports/
Documents related to the AGM, including previously published invitation, is available at:
https://www.promorepharma.com/en/annual-general-meeting-2022/
Printed copies of the annual report can be ordered from Promore Pharma AB, Fogdevreten 2, SE-171 65 Solna, or by e-mail: shareholders@promorepharma.com
About Promore Pharma
Promore Pharma is a biopharmaceutical company that develops pharmaceutical product candidates for bioactive wound care. Today, the company has two drug candidates in late clinical development stages, that are based on endogenous peptides, and thus have a strong safety profile. These two products are intended for treatment of chronic wounds, and prevention of scarring on the skin and other tissues. The company is listed on the Nasdaq First North Growth Market.
For additional information, please contact
Jonas Ekblom, CEO
Phone: [+46] 736 777 540
E-mail: jonas.ekblom@promorepharma.com
Erik Magnusson, CFO
Phone: [+46] 708 565 245
E-mail: erik.magnusson@promorepharma.com
Promore Pharmas Certified Adviser is Erik Penser Bank
Tel: [+46] 8-463 83 00
E-mail: certifiedadviser@penser.se
Link to the report on our site
The full interim report is available at https://www.promorepharma.com/en/section/investors/financial-reports/
Attachments
Promore Pharma AR 2021 ENG FINAL
SOURCE: Promore Pharma
View source version on accesswire.com:
https://www.accesswire.com/698911/Promore-Pharmas-Annual-Report-2021-and-AGM-related-Documents-Published
Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…
Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at…
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…
Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…